PLATINUM Long Lesion Trial
Platinum Chromium Everolimus-Eluting Clinical Experience
0% ARC ST (Def/Prob) and 0% TV-MI
PLATINUM Long Lesion Trial
2-Year Results2

4.8% TV-MI
SPIRIT PRIME Long Lesion Registry
2-Year Results in Perspective3,4


Submit Questions

Product Updates